bioRxivSystems BiologyPreprint
Reconstructing tumor trajectories during therapy through integration of multiple measurement modalities.
Jason I. GriffithsiD, Jinfeng CheniD, Onalisa D. WinbladiD, Anne P. O’DeaiD, Priyanka SharmaiD, Meghna S. TrivediiD, Kevin M. KalinskyiD, Kari Braun WisinskiiD, Ruth M O'ReganiD, Issam MakhouliD, Yuan YuaniD, Laura M. SpringiD, Aditya BardiaiD, Mohammad JahanzebiD, Frederick R. AdleriD, Adam Louis CoheniD, Andrea H. BildiD, Qamar J. KhaniD
- Citations
- 2
Abstract
BackgroundAccurately determining changes in tumor size during therapy is essential to evaluating response or progression. However, individual imaging methodologies often poorly reflect pathologic response and long-term treatment efficacy in patients with estrogen receptor positive (ER+) early-stage breast cancer. Mathematical models that measure tumor progression over time by integrating diverse imaging and tumor measurement modalities are not currently used but could increase accuracy in measuring response and provide biological insights into cancer evolution. MethodsFor ER+ breast cancer patients enrolled on a neoadjuvant clinical trial, we reconstructed their tumor size trajectories during therapy by combining all available information on tumor size, including different imaging modalities, physical examinations and pathological assessment data. Tumor trajectories during six months of treatment were generated, using a Gaussian process and the most probable trajectories were evaluated, based on clinical data, using measurement models that account for biases and differences in precision between tumor measurement methods, such as MRI, ultrasound and mammograms. ResultsReconstruction of tumor trajectories during treatment identified five distinct patterns of tumor size changes, including rebound growth not evident from any single modality. These results increase specificity to distinguish innate or acquired resistance compared to using any single measurement alone. The speed of therapeutic response and extent of subsequent rebound tumor growth quantify sensitivity or resistance in this patient population. ConclusionsTumor trajectory reconstruction integrating multiple modalities of tumor measurement accurately describes tumor progression on therapy and reveals various patterns of patient responses. Mathematical models can integrate diverse response assessments and account for biases in tumor measurement, thereby providing insights into the timing and rate at which resistance emerges.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multiscale Modeling of Cancer
Kerri-Ann Norton, Meghan McCabe Pryor, Aleksander S. Popel·bioRxiv·Dec 15, 2015
- Prediction of Individual Breast Cancer Evolution to Surgical Size
Cristian Axenie, Daria Kurz·bioRxiv·Jun 13, 2020
- Mathematical models of tumor volume dynamics in response to radiotherapy
N. Mohsin, H. U. Enderling, … M. U. Zahid·bioRxiv·Apr 7, 2022
- Towards personalized computer simulation of breast cancer treatment: a multi-scale pharmacokinetic and pharmacodynamic model informed by multi-type patient data
X. Lai, O. Geier, … A. Frigessi·bioRxiv·Jul 19, 2018
- Cancer Interception During Treatment: Using Growth Kinetics to Create a Continuous Variable for Assessing Disease Response
Mengxi Zhou, Antonio Tito Fojo, … Krastan B. Blagoev·The OncologistPeer-reviewed·Oct 18, 2025
- Intermittent hormonal therapy shows similar outcome than SOC in ER+ breast cancer preclinical model.
P. M. Enriquez Navas, L. Garcia, … R. A. Gatenby·bioRxiv·Jan 8, 2019